Lyon: HKEX(00388) "outperformed the market" rating upgraded to a target price of 374 Hong Kong dollars.
The line indicates that potential catalysts for the Hong Kong Stock Exchange include positive surprises in mainland policies, potential dividend tax breaks, and a more innovative three-year strategic plan.
Lyon released a research report claiming to give HKEX (00388) an "outperform the market" rating, with the target price raised from HKD 338 to HKD 374. Based on higher listing fee revenue and improved outlook in average daily turnover, profit forecasts for 2024 to 2026 have been adjusted upwards by 3%, 5%, and 10%, while revenue forecasts for the same period have been increased by 3%, 4%, and 7%.
Lyon believes that the recovery of IPOs and inflow of southbound funds will be the two fundamental drivers for HKEX this year. The bank expects strong performance in the fourth quarter of last year, with a projected 46% year-on-year growth in net profit after tax, earnings per share adjusted to HKD 10.28, and a dividend payout ratio of 90%. Lyon points out potential catalysts for HKEX including positive surprises in mainland policies, potential dividend tax breaks, and a more innovative three-year strategic plan.
Related Articles

Selected A-share Announcements | Star companies such as PetroChina (601857.SH) and Tianshan Aluminum Group (002532.SZ) have released their financial reports intensively.

New Stock News | Sinopec New Energy to hold a hearing at the Hong Kong Stock Exchange, with revenue expected to increase almost sevenfold year-on-year by 2025.

INSILICO (03696) released its financial report, adding over 10 collaborations and holding $393 million in cash.
Selected A-share Announcements | Star companies such as PetroChina (601857.SH) and Tianshan Aluminum Group (002532.SZ) have released their financial reports intensively.

New Stock News | Sinopec New Energy to hold a hearing at the Hong Kong Stock Exchange, with revenue expected to increase almost sevenfold year-on-year by 2025.

INSILICO (03696) released its financial report, adding over 10 collaborations and holding $393 million in cash.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


